[1]
M. Vaghela and P. Kapupara, “Overview of Post Approval Changes Requirements for Active Pharmaceutical Ingredients in Canada, Australia and Saudi Arabia”, ijpi, vol. 11, no. 4, pp. 349-353, Dec. 2021.